ELOVL1 (ELOVL fatty acid elongase 1)
Gene | |
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
64834 |
Gene name
Gene Name - the full gene name approved by the HGNC.
|
ELOVL fatty acid elongase 1 |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
ELOVL1 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
CGI-88, IKSHD, Ssc1 |
Disease Acronyms (UniProt)
Disease acronyms from UniProt database
|
IKSHD |
Chromosome
Chromosome number
|
1 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
1p34.2 |
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
Protein | |||||||||||
UniProt ID | Q9BW60 | ||||||||||
Protein name | Very long chain fatty acid elongase 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Elongation of very long chain fatty acids protein 1) (Very long chain 3-ketoacyl-CoA synthase 1) (Very long chain 3 | ||||||||||
Protein function | Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle (PubMed:29496980, PubMed:30487246). This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carb | ||||||||||
Family and domains |
Pfam
|
||||||||||
Tissue specificity | TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:20937905, ECO:0000269|PubMed:30487246}. | ||||||||||
Sequence |
|
||||||||||
Sequence length | 279 | ||||||||||
Interactions | View interactions |
Pathways
Pathway information has different metabolic/signaling pathways associated with genes.
|
|
Associated diseases
Disease information provided by ClinVar, GenCC, and GWAS databases.
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|